ArticleJournal of neurology2025

Efgartigimod-rituximab sequential therapy in Anti-NMDAR encephalitis: real-world evidence for a novel salvage-maintenance strategy.

Yao Tan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.